{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:38Z","timestamp":1740107738216,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Youth fund project","Grant NO.82201994"],"award-info":[{"award-number":["Youth fund project","Grant NO.82201994"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["General Program","Grant NO. ZR2022MH016","Youth fund project","Grant NO. ZR2021QH043"],"award-info":[{"award-number":["General Program","Grant NO. ZR2022MH016","Youth fund project","Grant NO. ZR2021QH043"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10067-024-07216-8","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:03:13Z","timestamp":1730448193000},"page":"3713-3722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypes of patients with lupus-associated pulmonary hypertension in the Chinese Han population: a cluster analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Yaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baocheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4745","authenticated-orcid":false,"given":"Zhenzhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"issue":"8","key":"7216_CR1","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1111\/jcmm.13672","volume":"22","author":"R Wang","year":"2018","unstructured":"Wang R, Wang CF, Qin HM et al (2018) Association between polymorphisms in the promoter region of miR-17\u201392 cluster and systemic lupus erythematosus in a Chinese population. J Cell Mol Med. 22(8):4016\u20134020. https:\/\/doi.org\/10.1111\/jcmm.13672","journal-title":"J Cell Mol Med."},{"issue":"1","key":"7216_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-023-03139-y","volume":"25","author":"M Dai","year":"2023","unstructured":"Dai M, Zhang C, Li C et al (2023) Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model. Arthritis Res Ther 25(1):155. https:\/\/doi.org\/10.1186\/s13075-023-03139-y","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"7216_CR3","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","volume":"42","author":"D\u00dc Cansu","year":"2023","unstructured":"Cansu D\u00dc, Korkmaz C (2023) Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment. Clin Rheumatol 42(10):2601\u20132610. https:\/\/doi.org\/10.1007\/s10067-022-06446-y","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7216_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10067-013-2383-3","volume":"33","author":"Y Fei","year":"2014","unstructured":"Fei Y, Shi X, Gan F et al (2014) Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33(1):57\u201363. https:\/\/doi.org\/10.1007\/s10067-013-2383-3","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7216_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu MP, Wang JH et al (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 16(1):19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr."},{"issue":"8","key":"7216_CR6","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"9","key":"7216_CR7","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7216_CR8","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2022) ESC\/ERS Scientific Document Group. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61(1):2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","journal-title":"Eur Respir J"},{"issue":"10","key":"7216_CR9","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"38","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E et al (2011) PHAROS Investigators Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 38(10):2172\u20139. https:\/\/doi.org\/10.3899\/jrheum.101243","journal-title":"J Rheumatol"},{"issue":"11","key":"7216_CR10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271\u20131277. https:\/\/doi.org\/10.1002\/art.1780251101","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7216_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200001000-00001","volume":"24","author":"AL Katzenstein","year":"2000","unstructured":"Katzenstein AL, Myers JL (2000) Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol 24(1):1\u20133. https:\/\/doi.org\/10.1097\/00000478-200001000-00001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"7216_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3899\/jrheum.130030","volume":"40","author":"Z Touma","year":"2013","unstructured":"Touma Z, Urowitz MB, Gladman DD (2013) Systemic lupus erythematosus disease activity index 2000 responder index-50 website. J Rheumatol 40(5):733. https:\/\/doi.org\/10.3899\/jrheum.130030","journal-title":"J Rheumatol"},{"issue":"5","key":"7216_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol. 12(5):825\u2013835. https:\/\/doi.org\/10.2215\/CJN.05780616","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"7216_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0961203310374305","volume":"19","author":"E Osio-Salido","year":"2010","unstructured":"Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19(12):1365\u20131373. https:\/\/doi.org\/10.1177\/0961203310374305","journal-title":"Lupus"},{"issue":"6","key":"7216_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/jalm\/jfac036","volume":"7","author":"N Alforaih","year":"2022","unstructured":"Alforaih N, Whittall-Garcia L, Touma Z (2022) A review of lupus nephritis. J Appl Lab Med 7(6):1450\u20131467. https:\/\/doi.org\/10.1093\/jalm\/jfac036","journal-title":"J Appl Lab Med"},{"issue":"7","key":"7216_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000517852","volume":"52","author":"M Radin","year":"2021","unstructured":"Radin M, Miraglia P, Barinotti A et al (2021) Prognostic and diagnostic values of novel serum and urine biomarkers in lupus nephritis: a systematic review. Am J Nephrol 52(7):559\u2013571. https:\/\/doi.org\/10.1159\/000517852","journal-title":"Am J Nephrol"},{"issue":"7","key":"7216_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/rheumatology\/kem112","volume":"46","author":"DA Isenberg","year":"2007","unstructured":"Isenberg DA, Manson JJ, Ehrenstein MR et al (2007) Fifty years of anti-ds DNA antibodies: are we approaching journey\u2019s end? Rheumatology (Oxford) 46(7):1052\u20131056. https:\/\/doi.org\/10.1093\/rheumatology\/kem112","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"7216_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1191\/0961203305lu2054oa","volume":"14","author":"M Waldman","year":"2005","unstructured":"Waldman M, Madaio MP (2005) Pathogenic autoantibodies in lupus nephritis. Lupus 14(1):19\u201324. https:\/\/doi.org\/10.1191\/0961203305lu2054oa","journal-title":"Lupus"},{"issue":"10","key":"7216_CR19","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"17","author":"X Wang","year":"2019","unstructured":"Wang X, Xia Y (2019) Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Front Immunol 17(10):1667. https:\/\/doi.org\/10.3389\/fimmu.2019.01667","journal-title":"Front Immunol"},{"issue":"8","key":"7216_CR20","doi-asserted-by":"publisher","first-page":"e71458","DOI":"10.1371\/journal.pone.0071458","volume":"8","author":"D Villalta","year":"2013","unstructured":"Villalta D, Bizzaro N, Bassi N et al (2013) Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS ONE 8(8):e71458. https:\/\/doi.org\/10.1371\/journal.pone.0071458","journal-title":"PLoS ONE"},{"issue":"11","key":"7216_CR21","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1002\/art.21379","volume":"52","author":"S Werwitzke","year":"2005","unstructured":"Werwitzke S, Trick D, Kamino K et al (2005) Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum 52(11):3629\u20133638. https:\/\/doi.org\/10.1002\/art.21379","journal-title":"Arthritis Rheum"},{"issue":"3","key":"7216_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1073\/pnas.97.3.1184","volume":"97","author":"M Boes","year":"2000","unstructured":"Boes M, Schmidt T, Linkemann K et al (2000) Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 97(3):1184\u20131189. https:\/\/doi.org\/10.1073\/pnas.97.3.1184","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7216_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12016-007-8046-x","volume":"34","author":"T Witte","year":"2008","unstructured":"Witte T (2008) IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol 34(3):345\u2013347. https:\/\/doi.org\/10.1007\/s12016-007-8046-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"7216_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10753-013-9675-2","volume":"36","author":"A Ahsen","year":"2013","unstructured":"Ahsen A, Ulu MS, Yuksel S et al (2013) As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36(6):1357\u20131362. https:\/\/doi.org\/10.1007\/s10753-013-9675-2","journal-title":"Inflammation"},{"issue":"10","key":"7216_CR25","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/ijc.28536","volume":"134","author":"MX Li","year":"2014","unstructured":"Li MX, Liu XM, Zhang XF et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer 134(10):2403\u20132413. https:\/\/doi.org\/10.1002\/ijc.28536","journal-title":"Int J Cancer"},{"issue":"6","key":"7216_CR26","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):dju124. https:\/\/doi.org\/10.1093\/jnci\/dju124","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"7216_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.amjcard.2008.05.006","volume":"102","author":"UU Tamhane","year":"2008","unstructured":"Tamhane UU, Aneja S, Montgomery D et al (2008) Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102(6):653\u2013657. https:\/\/doi.org\/10.1016\/j.amjcard.2008.05.006","journal-title":"Am J Cardiol"},{"issue":"7","key":"7216_CR28","first-page":"11026","volume":"8","author":"L Li","year":"2015","unstructured":"Li L, Xia Y, Chen C et al (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8(7):11026\u201331","journal-title":"Int J Clin Exp Med"},{"issue":"21","key":"7216_CR29","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim A, F\u00fcrnrohr BG, Amann K et al (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 107(21):9813\u20138. https:\/\/doi.org\/10.1073\/pnas.0909927107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"7216_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.asn.0000108969.21691.5d","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241\u2013250. https:\/\/doi.org\/10.1097\/01.asn.0000108969.21691.5d","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"7216_CR31","doi-asserted-by":"publisher","first-page":"e93009","DOI":"10.1172\/jci.insight.93009","volume":"2","author":"E Der","year":"2017","unstructured":"Der E, Ranabothu S, Suryawanshi H et al (2017) Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis. JCI Insight 2(9):e93009. https:\/\/doi.org\/10.1172\/jci.insight.93009","journal-title":"JCI Insight"},{"issue":"6","key":"7216_CR32","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1172\/JCI118924","volume":"98","author":"JB Lefkowith","year":"1996","unstructured":"Lefkowith JB, Kiehl M, Rubenstein J et al (1996) Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 98(6):1373\u20131380. https:\/\/doi.org\/10.1172\/JCI118924","journal-title":"J Clin Invest"},{"key":"7216_CR33","doi-asserted-by":"publisher","first-page":"980286","DOI":"10.1155\/2011\/980286","volume":"2011","author":"K Miyake","year":"2011","unstructured":"Miyake K, Akahoshi M, Nakashima H (2011) Th subset balance in lupus nephritis. J Biomed Biotechnol. 2011:980286. https:\/\/doi.org\/10.1155\/2011\/980286","journal-title":"J Biomed Biotechnol."},{"issue":"7","key":"7216_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der E, Suryawanshi H, Morozov P et al (2019) Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA\/SLE) Consortium. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 20(7):915\u2013927. https:\/\/doi.org\/10.1038\/s41590-019-0386-1","journal-title":"Nat Immunol."},{"issue":"11","key":"7216_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1741-7015-11-98","volume":"4","author":"D Carmona-Fernandes","year":"2013","unstructured":"Carmona-Fernandes D, Santos MJ, Canh\u00e3o H et al (2013) Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med 4(11):98. https:\/\/doi.org\/10.1186\/1741-7015-11-98","journal-title":"BMC Med"},{"issue":"1","key":"7216_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1128\/CVI.13.1.77-83.2006","volume":"13","author":"M Mahler","year":"2006","unstructured":"Mahler M, Kessenbrock K, Szmyrka M et al (2006) International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 13(1):77\u201383. https:\/\/doi.org\/10.1128\/CVI.13.1.77-83.2006","journal-title":"Clin Vaccine Immunol"},{"key":"7216_CR37","first-page":"3630","volume":"22","author":"Hu Zhigang","year":"2010","unstructured":"Zhigang Hu, Chen G, Zou Y et al (2010) Clinical application of anti-ribosomal P0 protein antibody in the diagnosis of systemic lupus erythematosus. Chin J Nosocomiology 22:3630\u20133632","journal-title":"Chin J Nosocomiology"},{"issue":"20","key":"7216_CR38","doi-asserted-by":"publisher","first-page":"e20192","DOI":"10.1097\/MD.0000000000020192","volume":"99","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo P, Guo T et al (2020) Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus. Medicine (Baltimore) 99(20):e20192. https:\/\/doi.org\/10.1097\/MD.0000000000020192","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"7216_CR39","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/art.21875","volume":"54","author":"AP de Nascimento","year":"2006","unstructured":"de Nascimento AP, VianaVdos V, de Abreu TL et al (2006) Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54(5):1568\u201372. https:\/\/doi.org\/10.1002\/art.21875","journal-title":"Arthritis Rheum"},{"issue":"2","key":"7216_CR40","first-page":"262","volume":"85","author":"KH Sun","year":"1995","unstructured":"Sun KH, Liu WT, Tsai CY et al (1995) Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology 85(2):262\u20139","journal-title":"Immunology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07216-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T11:05:25Z","timestamp":1732187125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07216-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7216"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07216-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Shandong Provincial Hospital, Shandong First Medical University (NSFC: no. 2022\u2013413). All participants signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}